Montelukast Prescribing at MCKENZIE GROUP PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
750
Total Quantity
20.4K
NHS Cost
£1.0K
vs National Avg
+9.5%
MCKENZIE GROUP PRACTICE prescribed 750 items of Montelukast over the last 12 months at a cost of £1,017 to the NHS. This is 9.5% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
77
Jun 2026
63
Jun 2026
71
Jun 2026
69
Jun 2026
64
Jun 2026
60
Jun 2026
58
Jun 2026
65
Jun 2026
55
Jun 2026
50
Jun 2026
60
Jun 2026
58
Prescribing Details
| Total Items | 750 |
|---|---|
| Total Quantity | 20,353 |
| Total NHS Cost | £1,017 |
| Presentations | 4 different forms |
| vs National Average | +9.5% |
Montelukast Prescribing Comparison
| This practice | 750 items |
|---|---|
| National average per practice | 685 items |
| Difference | +9.5% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.